Actionable insights straight to your inbox

logo_equities.svg

An Application for the Trademark “KINENZA” Has Been Filed by Eli Lilly

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “KINENZA” by Bruce W. Longbottom, representing Eli Lilly. This application was made available to the public on July 02, 2014 (see also Trademarks).
The serial number for this application is 86228627.
The international trademark goods and services class code for this trademark application is 005.
As submitted by the applicant, this trademark application relates to the following goods and services: Cancer pharmaceuticals sold on prescription.
The owner/registrar information for this application is: Bruce W. Longbottom, Eli Lilly, Lilly Corporate Center, Indianapolis, IN 46285-0001.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, Eli Lilly and Company.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

To say the current situation isn’t pretty now seems an understatement, and it’s likely to remain chaotic for a while. Which is why it’s so important for leaders of all kinds not to fall prey to the very human tendency to go negative, playing the blame game.
Bargain-hunting friends of mine have been asking: “Should I buy First Republic?” After all, First Republic is prestigious. Facebook founder Mark Zuckerberg got a mortgage there. Dozens of customer surveys rate its satisfaction scores higher than super-brands like Apple and Ritz-Carlton.
Many of us economy-watchers have been expecting recession, though with significant differences on odds and timing. Regardless, recent banking developments just made recession more likely and may have accelerated its onset.